Bartl's study indicated that baseline CSF GFAP was positively associated with baseline CSF α-syn, T-tau, P-tau, and Aβ42, suggesting that GFAP can be used as a predictor for examining pathological changes occurring in PD [16]. The gene discussed is GFAP; the disease is Parkinson disease.